September’s top cataract surgery articles involve postoperative inflammation therapies and cataract surgery in patients with uveitic glaucoma.
Netildex gel meets primary endpoint
A phase 3 trial demonstrated noninferiority of Netildex gel twice daily compared with solution four times daily to treat ocular inflammation after cataract surgery. Read more.
First pediatric patients dosed in phase 3 Dextenza trial
Ocular Therapeutix has dosed the first patients in a phase 3 clinical trial of Dextenza for postoperative ocular inflammation and pain in children after cataract surgery. Read more.
Uncategorized